This inventor holds 1 USPTO granted patent. Top assignee: Ucl Business Plc. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Adrian Hobbs - Innovator in Cardiovascular Treatment
Introduction
Adrian Hobbs is a notable inventor based in London, GB. He has made significant contributions to the field of medicine, particularly in the treatment of cardiovascular and inflammatory diseases. His innovative approach has led to the development of a unique compound that holds promise for improving patient outcomes.
Latest Patents
Adrian Hobbs holds 1 patent for his invention titled "Agents for use in the treatment of cardiovascular and inflammatory diseases structurally based on 4(1 H)-quinolone." This patent provides a compound of formula I, a tautomer thereof, or a pharmaceutically acceptable salt or N-oxide thereof for use in the treatment or prevention of cardiovascular disease or of an inflammatory disease or condition.
Career Highlights
Adrian Hobbs is associated with UCL Business Plc, where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in advancing therapeutic options for patients suffering from cardiovascular issues.
Collaborations
Adrian collaborates with David Lawrence Selwood, leveraging their combined expertise to enhance the impact of their research and innovations.
Conclusion
Adrian Hobbs exemplifies the spirit of innovation in the medical field, with his patent offering new hope for the treatment of cardiovascular and inflammatory diseases. His work continues to inspire advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile